HK

Harnish Kanubhai Patel

Active Director Director DIN 11243119
DIN 11243119 First appointment Aug 2025 Primary industry Consumer Products
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Harnish Kanubhai Patel

Data last updated:

Harnish Kanubhai Patel is a Director at Curepath International Private Limited (since 2025). The company operates in Consumer Products.

DIN 11243119
Primary Designation Director
Industry Consumer Products
First Appointment 14 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Aug 20252025Active

Directorship timeline

Open interactive timeline →
Curepath International Private Limited
Premium access

Shareholding and investment profile for Harnish Kanubhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Harnish Kanubhai Patel

Harnish Kanubhai Patel currently holds 1 directorship: Curepath International Private Limited (Director, since 14 Aug 2025).

Harnish Kanubhai Patel was first appointed on 14 Aug 2025 as Director at Curepath International Private Limited.

The current boards of Harnish Kanubhai Patel's companies include Anil Kumar Bhutra (Curepath International Private Limited), Brijeshkumar Bharatbhai Patel (Curepath International Private Limited), Hardik Kishorkumar Patel (Curepath International Private Limited), Vaibhav Avantilal Shah (Curepath International Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available